EpiTIL: methylation tumor infiltrating lymphocyte (TIL) predictor associates with survival in primary melanoma.

Edmiston SN, Liu S, Corcoran DL, Hao H, Parrish EA, Ollila DW, Googe PB, Kuan PF, Shen R, Parker JS, Orlow I, Busam KJ, Lezcano C, Conway K, Berwick M, Thomas NE

Open source

DOI: 10.1186/s13148-026-02226-6
Published: 2026 Aug 13
Container: Clinical epigenetics
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13148-026-02226-6,
  title = {EpiTIL: methylation tumor infiltrating lymphocyte (TIL) predictor associates with survival in primary melanoma.},
  author = {Edmiston SN and Liu S and Corcoran DL and Hao H and Parrish EA and Ollila DW and Googe PB and Kuan PF and Shen R and Parker JS and Orlow I and Busam KJ and Lezcano C and Conway K and Berwick M and Thomas NE},
  year = {2026},
  journal = {Clinical epigenetics},
  doi = {10.1186/s13148-026-02226-6},
  url = {https://doi.org/10.1186/s13148-026-02226-6}
}

RIS

TY  - JOUR
TI  - EpiTIL: methylation tumor infiltrating lymphocyte (TIL) predictor associates with survival in primary melanoma.
AU  - Edmiston SN
AU  - Liu S
AU  - Corcoran DL
AU  - Hao H
AU  - Parrish EA
AU  - Ollila DW
AU  - Googe PB
AU  - Kuan PF
AU  - Shen R
AU  - Parker JS
AU  - Orlow I
AU  - Busam KJ
AU  - Lezcano C
AU  - Conway K
AU  - Berwick M
AU  - Thomas NE
PY  - 2026
JO  - Clinical epigenetics
DO  - 10.1186/s13148-026-02226-6
UR  - https://doi.org/10.1186/s13148-026-02226-6
ER  -

APA

SN, E., S, L., DL, C., H, H., EA, P., DW, O., PB, G., PF, K., R, S., JS, P., I, O., KJ, B., C, L., K, C., M, B., & NE, T. (2026). EpiTIL: methylation tumor infiltrating lymphocyte (TIL) predictor associates with survival in primary melanoma.. Clinical epigenetics. https://doi.org/10.1186/s13148-026-02226-6

Source records

pubmed · retrieved 2026-11-10T16:53:02.981Z